Milton Eduardo Salazar-Hidalgo

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Venues

International journal of molecular sciences

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Ramos-Acosta, Laura Huerta-Pantoja, Milton Eduardo Salazar-Hidalgo, Elsa Mayol, Selene Jiménez-Vega, Pablo García-Peña, Jenifeer Jordi-Cruz, Cristina Baquero, Almudena Porras, Belén Íñigo-Rodríguez, Celina M Benavente, Andrea R López-Pastor, Irene Gómez-Delgado, Elena Urcelay, Francisco Javier Candel, Eduardo Anguita
Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production. International journal of molecular sciences 25 (9) (2024)
Carlos Ramos-Acosta, Laura Huerta-Pantoja, Milton Eduardo Salazar-Hidalgo, Elsa Mayol, Selene Jiménez-Vega, Pablo García-Peña, Jenifeer Jordi-Cruz, Cristina Baquero, Almudena Porras, Belén Íñigo-Rodríguez, Celina M Benavente, Andrea R López-Pastor, Irene Gómez-Delgado, Elena Urcelay, Francisco Javier Candel, Eduardo Anguita
Tigecycline Opposes Bortezomib Effect on Myeloma Cells Decreasing Mitochondrial Reactive Oxygen Species Production. International journal of molecular sciences 25 (9) (2024)
Erik Michel Marchena-Perea, Milton Eduardo Salazar-Hidalgo, Alicia Gómez-Sanz, Mónica Arranz-Ledo, Alicia Barroso, Victoria Fernández, Hugo Tejera-Pérez, Guillermo Pita, Rocío Núñez-Torres, Luz Pombo, Rafael Morales-Chamorro, Juana María Cano-Cano, Maria Del Carmen Soriano, Pilar Garre, Mercedes Durán, María Currás-Freixes, Miguel de la Hoya, Ana Osorio
A Large Case-Control Study Performed in Spanish Population Suggests That RECQL5 Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility. Cancers 14 (19) (2022)

Milton Eduardo Salazar-Hidalgo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Milton Eduardo Salazar-Hidalgo